Skip to search.
 TSX Up 0.37% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Cytori Therapeutics, Inc. (CYTX)

-NasdaqGM
2.34 Down 0.01(0.43%) Apr 17, 4:00PM EDT
Add to Portfolio
Prev Close:2.35
Open:2.35
Bid:2.20 x 3100
Ask:2.53 x 700
1y Target Est:8.25
Beta:2.32
Next Earnings Date:N/A
Day's Range:2.30 - 2.46
52wk Range:2.00 - 3.93
Volume:215,247
Avg Vol (3m):550,448
Market Cap:176.55M
P/E (ttm):N/A
EPS (ttm):-0.39
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CYTXDown 0.43%176.55M
ASTMDown 3.03%21.68M
BAXDown 0.87%39.55B
OSIRDown 3.20%424.00M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.54
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.43
Quarterly EPS Est (Mar-14) :-0.14
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a cell therapy company, develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback